Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Buchsbaum

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1996
Experimental radioimmunotherapy: biological effectiveness and comparison with external beam radiationD J Buchsbaum, P L Roberson
Targeted Diagnosis and Therapy|January 1, 1990
New trends in the use of radioimmunoconjugates for the therapy of cancerD J Buchsbaum, T S Lawrence
Journal of Biopharmaceutical Statistics|May 10, 2000
A robust summarize-regress procedure for tissue-specific pharmacokineticsM S Mayo, D J Buchsbaum
Medical Physics|March 1, 1993
Introduction: radiolabeled antibody tumor dosimetryD J Buchsbaum, B W Wessels
Gene Therapy|August 2, 2000
Radiation to control gene expressionM A Stackhouse, D J Buchsbaum
Cancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Synthesis and biodistribution of peptide based 99mTc/186Re-MAGIPG-D612 monoclonal antibody in nude mice bearing colon cancer xenograftsS Ram, W Merriwether, D J Buchsbaum
Bioconjugate Chemistry|May 1, 1993
Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agentsA Safavy, D J Buchsbaum, M B Khazaeli
Cancer|December 24, 1997
Dosimetric comparison of bolus and continuous injections of CC49 monoclonal antibody in a colon cancer xenograft modelP L Roberson, S Dudek, D J Buchsbaum
Bioconjugate Chemistry|November 5, 1997
Conjugation of unprotected trisuccin, N-[tris[2-[(N-hydroxyamino)carbonyl]ethyl]methyl]succinamic acid, to monoclonal antibody CC49 by an improved active ester protocolA Safavy, A Sanders, H Qin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxinsJ M Manske, D J Buchsbaum, D A Vallera
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1996
Experimental radioimmunotherapy: biological effectiveness and comparison with external beam radiationD J Buchsbaum, P L Roberson
Targeted Diagnosis and Therapy|January 1, 1990
New trends in the use of radioimmunoconjugates for the therapy of cancerD J Buchsbaum, T S Lawrence
Journal of Biopharmaceutical Statistics|May 10, 2000
A robust summarize-regress procedure for tissue-specific pharmacokineticsM S Mayo, D J Buchsbaum
Medical Physics|March 1, 1993
Introduction: radiolabeled antibody tumor dosimetryD J Buchsbaum, B W Wessels
Gene Therapy|August 2, 2000
Radiation to control gene expressionM A Stackhouse, D J Buchsbaum
Cancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Synthesis and biodistribution of peptide based 99mTc/186Re-MAGIPG-D612 monoclonal antibody in nude mice bearing colon cancer xenograftsS Ram, W Merriwether, D J Buchsbaum
Bioconjugate Chemistry|May 1, 1993
Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agentsA Safavy, D J Buchsbaum, M B Khazaeli
Cancer|December 24, 1997
Dosimetric comparison of bolus and continuous injections of CC49 monoclonal antibody in a colon cancer xenograft modelP L Roberson, S Dudek, D J Buchsbaum
Bioconjugate Chemistry|November 5, 1997
Conjugation of unprotected trisuccin, N-[tris[2-[(N-hydroxyamino)carbonyl]ethyl]methyl]succinamic acid, to monoclonal antibody CC49 by an improved active ester protocolA Safavy, A Sanders, H Qin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxinsJ M Manske, D J Buchsbaum, D A Vallera
Pageof 10